Donn Bullens, J.R., N.P.; Decision and Order, 21721-21722 [2023-07501]
Download as PDF
Federal Register / Vol. 88, No. 69 / Tuesday, April 11, 2023 / Notices
Massachusetts controlled substance
registration (hereinafter, MCSR).
RFAAX 3, Attachment D.2
According to Massachusetts online
records, of which the Agency takes
official notice, Registrant’s MCSR is
terminated.3 Massachusetts Health
Professions License Verification Site,
https://madph.mylicense.com/
verification (last visited date of
signature of this Order).4 Accordingly,
the Agency finds that Registrant is not
authorized to handle controlled
substances in Massachusetts, the state in
which he is registered with the DEA.
Discussion
Pursuant to 21 U.S.C. 824(a)(3), the
Attorney General is authorized to
suspend or revoke a registration issued
under section 823 of the Controlled
Substances Act (hereinafter, CSA)
‘‘upon a finding that the registrant . . .
has had his State license or registration
suspended . . . [or] revoked . . . by
competent State authority and is no
longer authorized by State law to engage
in the . . . dispensing of controlled
substances.’’ With respect to a
practitioner, the DEA has also long held
that the possession of authority to
dispense controlled substances under
the laws of the state in which a
practitioner engages in professional
practice is a fundamental condition for
obtaining and maintaining a
practitioner’s registration. See, e.g.,
James L. Hooper, M.D., 76 FR 71371
(2011), pet. for rev. denied, 481 F. App’x
826 (4th Cir. 2012); Frederick Marsh
lotter on DSK11XQN23PROD with NOTICES1
2 The
letter states that Registrant ‘‘is no longer
authorized to prescribe, distribute, possess,
dispense, or administer controlled substances in the
Commonwealth of Massachusetts.’’ Id. Moreover,
on February 2, 2023, the Massachusetts Board of
Registration in Medicine issued a Final Decision
and Order revoking Registrant’s Massachusetts
medical license. RFAAX 3, Attachment E, at 1, 6.
3 Under the Administrative Procedure Act, an
agency ‘‘may take official notice of facts at any stage
in a proceeding—even in the final decision.’’
United States Department of Justice, Attorney
General’s Manual on the Administrative Procedure
Act 80 (1947) (Wm. W. Gaunt & Sons, Inc., Reprint
1979). Pursuant to 5 U.S.C. 556(e), ‘‘[w]hen an
agency decision rests on official notice of a material
fact not appearing in the evidence in the record, a
party is entitled, on timely request, to an
opportunity to show the contrary.’’ Accordingly,
Registrant may dispute the Agency’s finding by
filing a properly supported motion for
reconsideration of findings of fact within fifteen
calendar days of the date of this Order. Any such
motion and response shall be filed and served by
email to the other party and to the DEA Office of
the Administrator, Drug Enforcement
Administration at dea.addo.attorneys@dea.gov.
4 Further, Registrant’s Massachusetts medical
license is revoked. Massachusetts Board of
Registration in Medicine Physician License
Verification Site, https://findmydoctor.mass.gov
(last visited date of signature of this Order).
VerDate Sep<11>2014
17:45 Apr 10, 2023
Jkt 259001
Blanton, M.D., 43 FR 27616, 27617
(1978).5
According to the Massachusetts
Controlled Substances Act, ‘‘every
person who manufactures, distributes or
dispenses, or possesses with intent to
manufacture, distribute or dispense any
controlled substance within the
commonwealth shall . . . register with
the commissioner of public health, in
accordance with his regulations . . . .’’
Mass. Gen. Laws. ch. 94C, § 7(a) (2022).
Further, ‘‘[a] prescription for a
controlled substance may be issued only
by a practitioner who is: (1) authorized
to prescribe controlled substances; and
(2) registered pursuant to the provisions
of [the Massachusetts Controlled
Substances Act].’’ Id. at § 18(a).
Here, the undisputed evidence in the
record is that Registrant lacks authority
to handle controlled substances in
Massachusetts because Registrant’s
MCSR was terminated. As already
discussed, a practitioner must hold a
valid controlled substance registration
to dispense a controlled substance in
Massachusetts. Thus, because Registrant
lacks state authority to handle
controlled substances, Registrant is not
eligible to maintain a DEA registration.
Accordingly, the Agency will order that
Registrant’s DEA registration be
revoked.
Order
Pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
824(a), I hereby revoke DEA Certificate
of Registration No. AS7987348 issued to
Thomas W. Stinson, III, M.D. Further,
pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
823(g)(1), I hereby deny any pending
5 This
rule derives from the text of two provisions
of the CSA. First, Congress defined the term
‘‘practitioner’’ to mean ‘‘a physician . . . or other
person licensed, registered, or otherwise permitted,
by . . . the jurisdiction in which he practices . . . ,
to distribute, dispense, . . . [or] administer . . . a
controlled substance in the course of professional
practice.’’ 21 U.S.C. 802(21). Second, in setting the
requirements for obtaining a practitioner’s
registration, Congress directed that ‘‘[t]he Attorney
General shall register practitioners . . . if the
applicant is authorized to dispense . . . controlled
substances under the laws of the State in which he
practices.’’ 21 U.S.C. 823(g)(1) (this section,
formerly § 823(f), was redesignated as part of the
Medical Marijuana and Cannabidiol Research
Expansion Act, Pub. L. 117–215, 136 Stat. 2257
(2022)). Because Congress has clearly mandated that
a practitioner possess state authority in order to be
deemed a practitioner under the CSA, the DEA has
held repeatedly that revocation of a practitioner’s
registration is the appropriate sanction whenever he
is no longer authorized to dispense controlled
substances under the laws of the state in which he
practices. See, e.g., James L. Hooper, 76 FR at
71371–72; Sheran Arden Yeates, M.D., 71 FR
39130, 39131 (2006); Dominick A. Ricci, M.D., 58
FR 51104, 51105 (1993); Bobby Watts, M.D., 53 FR
11919, 11920 (1988); Frederick Marsh Blanton, 43
FR at 27617.
PO 00000
Frm 00120
Fmt 4703
Sfmt 4703
21721
applications of Thomas W. Stinson, III,
M.D., to renew or modify this
registration, as well as any other
pending application of Thomas W.
Stinson, III, M.D., for additional
registration in Massachusetts. This
Order is effective May 11, 2023.
Signing Authority
This document of the Drug
Enforcement Administration was signed
on April 4, 2023, by Administrator
Anne Milgram. That document with the
original signature and date is
maintained by DEA. For administrative
purposes only, and in compliance with
requirements of the Office of the Federal
Register, the undersigned DEA Federal
Register Liaison Officer has been
authorized to sign and submit the
document in electronic format for
publication, as an official document of
DEA. This administrative process in no
way alters the legal effect of this
document upon publication in the
Federal Register.
Heather Achbach,
Federal Register Liaison Officer, Drug
Enforcement Administration.
[FR Doc. 2023–07508 Filed 4–10–23; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 23–3]
Donn Bullens, J.R., N.P.; Decision and
Order
On September 7, 2022, the Drug
Enforcement Administration
(hereinafter, DEA or Government)
issued an Order to Show Cause
(hereinafter, OSC) to Donn Bullens, Jr.,
N.P. (hereinafter, Registrant). Request
for Final Agency Action (hereinafter,
RFAA), Exhibit (hereinafter, RFAAX) 2
(OSC), at 1, 3. The OSC proposed the
revocation of Registrant’s Certificate of
Registration No. MB4611744 at the
registered address of 227 Babcock
Street, Brookline, MA 02446. Id. at 1.
The OSC alleged that Registrant’s
registration should be revoked because
Registrant is ‘‘currently without
authority to handle controlled
substances in the Commonwealth of
Massachusetts, the state in which [he is]
registered with DEA.’’ Id. at 2 (citing 21
U.S.C. 824(a)(3)).
The Agency makes the following
findings of fact based on the
uncontroverted evidence submitted by
E:\FR\FM\11APN1.SGM
11APN1
21722
Federal Register / Vol. 88, No. 69 / Tuesday, April 11, 2023 / Notices
the Government in its RFAA dated
February 22, 2023.1
the state in which he is registered with
the DEA.
Findings of Fact
On September 7, 2021, the
Massachusetts Drug Control Program
issued a letter to Registrant accepting
Registrant’s voluntary surrender of his
Massachusetts controlled substance
registration (hereinafter, MCSR).
RFAAX 3, Attachment D.2 According to
Massachusetts online records, of which
the Agency takes official notice,
Registrant’s MCSR was voluntarily
surrendered and is expired.3
Massachusetts Health Professions
License Verification Site, https://
madph.mylicense.com/verification (last
visited date of signature of this Order).4
Accordingly, the Agency finds that
Registrant is not authorized to handle
controlled substances in Massachusetts,
Discussion
Pursuant to 21 U.S.C. 824(a)(3), the
Attorney General is authorized to
suspend or revoke a registration issued
under section 823 of the Controlled
Substances Act (hereinafter, CSA)
‘‘upon a finding that the registrant . . .
has had his State license or registration
suspended . . . [or] revoked . . . by
competent State authority and is no
longer authorized by State law to engage
in the . . . dispensing of controlled
substances.’’ With respect to a
practitioner, the DEA has also long held
that the possession of authority to
dispense controlled substances under
the laws of the state in which a
practitioner engages in professional
practice is a fundamental condition for
obtaining and maintaining a
practitioner’s registration. See, e.g.,
James L. Hooper, M.D., 76 FR 71371
(2011), pet. for rev. denied, 481 F. App’x
826 (4th Cir. 2012); Frederick Marsh
Blanton, M.D., 43 FR 27616, 27617
(1978).5
According to the Massachusetts
Controlled Substances Act, ‘‘every
person who manufactures, distributes or
dispenses, or possesses with intent to
manufacture, distribute or dispense any
controlled substance within the
commonwealth shall . . . register with
the commissioner of public health, in
accordance with his regulations . . . .’’
Mass. Gen. Laws. ch. 94C, § 7(a) (2022).
Further, ‘‘[a] prescription for a
controlled substance may be issued only
by a practitioner who is: (1) authorized
to prescribe controlled substances; and
(2) registered pursuant to the provisions
lotter on DSK11XQN23PROD with NOTICES1
1 On
November 1, 2022, Registrant represented
that he was not served with the OSC until October
21, 2022, and requested a thirty-day extension to
determine whether to request a hearing. RFFAX 4,
at 1. On November 7, 2022, the Government filed
a Notice of Filing of Evidence Regarding Proof of
Service agreeing that Registrant had not been served
with the OSC until October 21, 2022 and thus that
Registrant’s extension request was timely. Id. On
November 7, 2022, Administrative Law Judge
Teresa A. Wallbaum (hereinafter, the ALJ) issued an
Order Granting in Part [Registrant’s] Extension
Request to File a Request for Hearing that gave
Registrant until 2:00 p.m. on December 5, 2022 to
file a Request for Hearing. Id. at 1, 3. On December
6, 2022, the ALJ issued an Order Terminating
Proceedings, indicating that, as of December 6,
2022, Registrant had not filed anything with the
tribunal. RFAAX 5, at 1.
2 The letter states, ‘‘[u]pon receipt of this letter,
you are no longer authorized to prescribe,
distribute, possess, dispense or administer
controlled substances in Massachussets.’’ Id. On
September 9, 2021, Registrant signed the letter to
confirm that he had received it and had voluntarily
surrendered his MCSR as of that date. Id. Further,
on September 9, 2021, the Massachusetts Board of
Registration in Nursing issued an Order of
Summary Suspension and Notice of Hearing that
suspended both Registrant’s Massachusetts
registered nurse license and Registrant’s
Massachusetts certified nurse practitioner
authorization. RFAAX 3, Attachment E, at 1 and 4.
3 Under the Administrative Procedure Act, an
agency ‘‘may take official notice of facts at any stage
in a proceeding—even in the final decision.’’
United States Department of Justice, Attorney
General’s Manual on the Administrative Procedure
Act 80 (1947) (Wm. W. Gaunt & Sons, Inc., Reprint
1979). Pursuant to 5 U.S.C. 556(e), ‘‘[w]hen an
agency decision rests on official notice of a material
fact not appearing in the evidence in the record, a
party is entitled, on timely request, to an
opportunity to show the contrary.’’ Accordingly,
Registrant may dispute the Agency’s finding by
filing a properly supported motion for
reconsideration of findings of fact within fifteen
calendar days of the date of this Order. Any such
motion and response shall be filed and served by
email to the other party and to the DEA Office of
the Administrator, Drug Enforcement
Administration at dea.addo.attorneys@dea.gov.
4 Further, both Registrant’s Massachusetts
registered nurse license and Registrant’s
Massachusetts certified nurse practitioner
authorization are listed as suspended and expired.
Id.
VerDate Sep<11>2014
17:45 Apr 10, 2023
Jkt 259001
5 This rule derives from the text of two provisions
of the CSA. First, Congress defined the term
‘‘practitioner’’ to mean ‘‘a physician . . . or other
person licensed, registered, or otherwise permitted,
by . . . the jurisdiction in which he practices . . . ,
to distribute, dispense, . . . [or] administer . . . a
controlled substance in the course of professional
practice.’’ 21 U.S.C. 802(21). Second, in setting the
requirements for obtaining a practitioner’s
registration, Congress directed that ‘‘[t]he Attorney
General shall register practitioners . . . if the
applicant is authorized to dispense . . . controlled
substances under the laws of the State in which he
practices.’’ 21 U.S.C. 823(g)(1) (this section,
formerly § 823(f), was redesignated as part of the
Medical Marijuana and Cannabidiol Research
Expansion Act, Pub. L. 117–215, 136 Stat. 2257
(2022)). Because Congress has clearly mandated that
a practitioner possess state authority in order to be
deemed a practitioner under the CSA, the DEA has
held repeatedly that revocation of a practitioner’s
registration is the appropriate sanction whenever he
is no longer authorized to dispense controlled
substances under the laws of the state in which he
practices. See, e.g., James L. Hooper, 76 FR at
71371–72; Sheran Arden Yeates, M.D., 71 FR
39130, 39131 (2006); Dominick A. Ricci, M.D., 58
FR 51104, 51105 (1993); Bobby Watts, M.D., 53 FR
11919, 11920 (1988); Frederick Marsh Blanton, 43
FR at 27617.
PO 00000
Frm 00121
Fmt 4703
Sfmt 9990
of [the Massachusetts Controlled
Substances Act].’’ Id. at § 18(a).
Here, the undisputed evidence in the
record is that Registrant lacks authority
to handle controlled substances in
Massachusetts because Registrant
voluntarily surrendered his MCSR and
his MCSR has expired. As already
discussed, a practitioner must hold a
valid controlled substance registration
to dispense a controlled substance in
Massachusetts. Thus, because Registrant
lacks state authority to handle
controlled substances, Registrant is not
eligible to maintain a DEA registration.
Accordingly, the Agency will order that
Registrant’s DEA registration be
revoked.
Order
Pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
824(a), I hereby revoke DEA Certificate
of Registration No. MB4611744 issued
to Donn Bullens, Jr., N.P. Further,
pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
823(g)(1), I hereby deny any pending
applications of Donn Bullens, Jr., N.P.,
to renew or modify this registration, as
well as any other pending application of
Donn Bullens, Jr., N.P., for additional
registration in Massachusetts. This
Order is effective May 11, 2023.
Signing Authority
This document of the Drug
Enforcement Administration was signed
on April 4, 2023, by Administrator
Anne Milgram. That document with the
original signature and date is
maintained by DEA. For administrative
purposes only, and in compliance with
requirements of the Office of the Federal
Register, the undersigned DEA Federal
Register Liaison Officer has been
authorized to sign and submit the
document in electronic format for
publication, as an official document of
DEA. This administrative process in no
way alters the legal effect of this
document upon publication in the
Federal Register.
Heather Achbach,
Federal Register Liaison Officer, Drug
Enforcement Administration.
[FR Doc. 2023–07501 Filed 4–10–23; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\11APN1.SGM
11APN1
Agencies
[Federal Register Volume 88, Number 69 (Tuesday, April 11, 2023)]
[Notices]
[Pages 21721-21722]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-07501]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 23-3]
Donn Bullens, J.R., N.P.; Decision and Order
On September 7, 2022, the Drug Enforcement Administration
(hereinafter, DEA or Government) issued an Order to Show Cause
(hereinafter, OSC) to Donn Bullens, Jr., N.P. (hereinafter,
Registrant). Request for Final Agency Action (hereinafter, RFAA),
Exhibit (hereinafter, RFAAX) 2 (OSC), at 1, 3. The OSC proposed the
revocation of Registrant's Certificate of Registration No. MB4611744 at
the registered address of 227 Babcock Street, Brookline, MA 02446. Id.
at 1. The OSC alleged that Registrant's registration should be revoked
because Registrant is ``currently without authority to handle
controlled substances in the Commonwealth of Massachusetts, the state
in which [he is] registered with DEA.'' Id. at 2 (citing 21 U.S.C.
824(a)(3)).
The Agency makes the following findings of fact based on the
uncontroverted evidence submitted by
[[Page 21722]]
the Government in its RFAA dated February 22, 2023.\1\
---------------------------------------------------------------------------
\1\ On November 1, 2022, Registrant represented that he was not
served with the OSC until October 21, 2022, and requested a thirty-
day extension to determine whether to request a hearing. RFFAX 4, at
1. On November 7, 2022, the Government filed a Notice of Filing of
Evidence Regarding Proof of Service agreeing that Registrant had not
been served with the OSC until October 21, 2022 and thus that
Registrant's extension request was timely. Id. On November 7, 2022,
Administrative Law Judge Teresa A. Wallbaum (hereinafter, the ALJ)
issued an Order Granting in Part [Registrant's] Extension Request to
File a Request for Hearing that gave Registrant until 2:00 p.m. on
December 5, 2022 to file a Request for Hearing. Id. at 1, 3. On
December 6, 2022, the ALJ issued an Order Terminating Proceedings,
indicating that, as of December 6, 2022, Registrant had not filed
anything with the tribunal. RFAAX 5, at 1.
---------------------------------------------------------------------------
Findings of Fact
On September 7, 2021, the Massachusetts Drug Control Program issued
a letter to Registrant accepting Registrant's voluntary surrender of
his Massachusetts controlled substance registration (hereinafter,
MCSR). RFAAX 3, Attachment D.\2\ According to Massachusetts online
records, of which the Agency takes official notice, Registrant's MCSR
was voluntarily surrendered and is expired.\3\ Massachusetts Health
Professions License Verification Site, https://madph.mylicense.com/verification (last visited date of signature of this Order).\4\
Accordingly, the Agency finds that Registrant is not authorized to
handle controlled substances in Massachusetts, the state in which he is
registered with the DEA.
---------------------------------------------------------------------------
\2\ The letter states, ``[u]pon receipt of this letter, you are
no longer authorized to prescribe, distribute, possess, dispense or
administer controlled substances in Massachussets.'' Id. On
September 9, 2021, Registrant signed the letter to confirm that he
had received it and had voluntarily surrendered his MCSR as of that
date. Id. Further, on September 9, 2021, the Massachusetts Board of
Registration in Nursing issued an Order of Summary Suspension and
Notice of Hearing that suspended both Registrant's Massachusetts
registered nurse license and Registrant's Massachusetts certified
nurse practitioner authorization. RFAAX 3, Attachment E, at 1 and 4.
\3\ Under the Administrative Procedure Act, an agency ``may take
official notice of facts at any stage in a proceeding--even in the
final decision.'' United States Department of Justice, Attorney
General's Manual on the Administrative Procedure Act 80 (1947) (Wm.
W. Gaunt & Sons, Inc., Reprint 1979). Pursuant to 5 U.S.C. 556(e),
``[w]hen an agency decision rests on official notice of a material
fact not appearing in the evidence in the record, a party is
entitled, on timely request, to an opportunity to show the
contrary.'' Accordingly, Registrant may dispute the Agency's finding
by filing a properly supported motion for reconsideration of
findings of fact within fifteen calendar days of the date of this
Order. Any such motion and response shall be filed and served by
email to the other party and to the DEA Office of the Administrator,
Drug Enforcement Administration at [email protected].
\4\ Further, both Registrant's Massachusetts registered nurse
license and Registrant's Massachusetts certified nurse practitioner
authorization are listed as suspended and expired. Id.
---------------------------------------------------------------------------
Discussion
Pursuant to 21 U.S.C. 824(a)(3), the Attorney General is authorized
to suspend or revoke a registration issued under section 823 of the
Controlled Substances Act (hereinafter, CSA) ``upon a finding that the
registrant . . . has had his State license or registration suspended .
. . [or] revoked . . . by competent State authority and is no longer
authorized by State law to engage in the . . . dispensing of controlled
substances.'' With respect to a practitioner, the DEA has also long
held that the possession of authority to dispense controlled substances
under the laws of the state in which a practitioner engages in
professional practice is a fundamental condition for obtaining and
maintaining a practitioner's registration. See, e.g., James L. Hooper,
M.D., 76 FR 71371 (2011), pet. for rev. denied, 481 F. App'x 826 (4th
Cir. 2012); Frederick Marsh Blanton, M.D., 43 FR 27616, 27617
(1978).\5\
---------------------------------------------------------------------------
\5\ This rule derives from the text of two provisions of the
CSA. First, Congress defined the term ``practitioner'' to mean ``a
physician . . . or other person licensed, registered, or otherwise
permitted, by . . . the jurisdiction in which he practices . . . ,
to distribute, dispense, . . . [or] administer . . . a controlled
substance in the course of professional practice.'' 21 U.S.C.
802(21). Second, in setting the requirements for obtaining a
practitioner's registration, Congress directed that ``[t]he Attorney
General shall register practitioners . . . if the applicant is
authorized to dispense . . . controlled substances under the laws of
the State in which he practices.'' 21 U.S.C. 823(g)(1) (this
section, formerly Sec. 823(f), was redesignated as part of the
Medical Marijuana and Cannabidiol Research Expansion Act, Pub. L.
117-215, 136 Stat. 2257 (2022)). Because Congress has clearly
mandated that a practitioner possess state authority in order to be
deemed a practitioner under the CSA, the DEA has held repeatedly
that revocation of a practitioner's registration is the appropriate
sanction whenever he is no longer authorized to dispense controlled
substances under the laws of the state in which he practices. See,
e.g., James L. Hooper, 76 FR at 71371-72; Sheran Arden Yeates, M.D.,
71 FR 39130, 39131 (2006); Dominick A. Ricci, M.D., 58 FR 51104,
51105 (1993); Bobby Watts, M.D., 53 FR 11919, 11920 (1988);
Frederick Marsh Blanton, 43 FR at 27617.
---------------------------------------------------------------------------
According to the Massachusetts Controlled Substances Act, ``every
person who manufactures, distributes or dispenses, or possesses with
intent to manufacture, distribute or dispense any controlled substance
within the commonwealth shall . . . register with the commissioner of
public health, in accordance with his regulations . . . .'' Mass. Gen.
Laws. ch. 94C, Sec. 7(a) (2022). Further, ``[a] prescription for a
controlled substance may be issued only by a practitioner who is: (1)
authorized to prescribe controlled substances; and (2) registered
pursuant to the provisions of [the Massachusetts Controlled Substances
Act].'' Id. at Sec. 18(a).
Here, the undisputed evidence in the record is that Registrant
lacks authority to handle controlled substances in Massachusetts
because Registrant voluntarily surrendered his MCSR and his MCSR has
expired. As already discussed, a practitioner must hold a valid
controlled substance registration to dispense a controlled substance in
Massachusetts. Thus, because Registrant lacks state authority to handle
controlled substances, Registrant is not eligible to maintain a DEA
registration. Accordingly, the Agency will order that Registrant's DEA
registration be revoked.
Order
Pursuant to 28 CFR 0.100(b) and the authority vested in me by 21
U.S.C. 824(a), I hereby revoke DEA Certificate of Registration No.
MB4611744 issued to Donn Bullens, Jr., N.P. Further, pursuant to 28 CFR
0.100(b) and the authority vested in me by 21 U.S.C. 823(g)(1), I
hereby deny any pending applications of Donn Bullens, Jr., N.P., to
renew or modify this registration, as well as any other pending
application of Donn Bullens, Jr., N.P., for additional registration in
Massachusetts. This Order is effective May 11, 2023.
Signing Authority
This document of the Drug Enforcement Administration was signed on
April 4, 2023, by Administrator Anne Milgram. That document with the
original signature and date is maintained by DEA. For administrative
purposes only, and in compliance with requirements of the Office of the
Federal Register, the undersigned DEA Federal Register Liaison Officer
has been authorized to sign and submit the document in electronic
format for publication, as an official document of DEA. This
administrative process in no way alters the legal effect of this
document upon publication in the Federal Register.
Heather Achbach,
Federal Register Liaison Officer, Drug Enforcement Administration.
[FR Doc. 2023-07501 Filed 4-10-23; 8:45 am]
BILLING CODE 4410-09-P